Article
Single-cell genomics in AML: extending the frontiers of AML research
4 Aug 2022
Abstract excerpt
The era of genomic medicine has allowed acute myeloid leukemia (AML) researchers to improve disease characterization, optimize risk-stratification systems, and develop new treatments. Although there has been significant progress, AML remains a lethal cancer because of its remarkably complex and plastic cellular architecture. This degree of heterogeneity continues to pose a major challenge, because it limits the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
